The biopharma world's manufacturing weekly

Endpoints Manufacturing

Manufacturing channel feed

No­var­tis fol­lows Lil­ly and J&J in an­nounc­ing multi­bil­lion-dol­lar US man­u­fac­tur­ing in­vest­ment

Last month
Pharma

Phar­ma tar­iffs: Here’s what a po­ten­tial roll­out could look like

Last month
Pharma

DHL pours €2B in­to health­care lo­gis­tics; OXB rev­enues on the rise

Last month

No­vo Nordisk looks to Brazil to boost GLP-1 man­u­fac­tur­ing with $1B+ bud­get

Last month
Pharma

Up­dat­ed: Phar­ma is next in line as Trump says tar­iffs are com­ing 'very short­ly'

Last month
Pharma

Phar­ma CEOs warn EU of po­ten­tial ‘ex­o­dus to the US’ as trade war con­tin­ues

Last month
Pharma

Drug tool and pack­ag­ing mak­ers to feel brunt of Trump tar­iffs, an­a­lysts say

Last month
Pharma

Cell and gene ther­a­py CD­MO Am­pli­fy­Bio shuts down over 's­carci­ty' of fund­ing

Last month
Cell/Gene Tx

Chi­na's re­tal­ia­to­ry tar­iffs on US could mean more head­winds for drug­mak­ers

Last month
China
Pharma

SHL Med­ical opens $220M au­toin­jec­tor site; DHL ac­quires clin­i­cal tri­al firm 

Last month

Chaot­ic tar­iff roll­out leaves as many ques­tions as an­swers for drug­mak­ers

Last month
Pharma

Trump’s broad tar­iffs ex­empt phar­ma — but for how long?

Last month
Pharma
FDA+

New CD­MO emerges, ac­quires cell and gene man­u­fac­tur­er Land­mark Bio

Last month
Deals
Cell/Gene Tx

Mile­stone's shares dive af­ter FDA again re­jects drug for ab­nor­mal heart rhythm

2 months ago
Pharma

With tar­iffs on the way, gener­ic drug­mak­ing woes could hin­der Trump’s reshoring plan 

2 months ago
Pharma

Chiesi pours €430 in­to new Italy site; Bharat’s first CGT site in In­dia

2 months ago

WuXi Bi­o­log­ics’ li­cens­ing deals help off­set Biose­cure threat in the US

2 months ago
Deals
China

Three ma­jor ques­tions on phar­ma tar­iffs Trump claims are on the way

2 months ago
Pharma

Liv­er can­cer drug com­bo gets sec­ond FDA re­jec­tion over man­u­fac­tur­ing is­sues

2 months ago
Pharma
FDA+

As­traZeneca puts $2.5B to­ward first vac­cine fac­to­ry and sec­ond R&D site in Chi­na

2 months ago
R&D
China

John­son & John­son ear­marks $55B to boost US ca­pac­i­ty 

2 months ago
Pharma

Mer­ck to lay off 163 work­ers in Penn­syl­va­nia; Del­pharm gets $60M from Cana­di­an gov­ern­ment 

2 months ago

WuXi AppTec's US rev­enue growth con­tin­ues to dip in post-Biose­cure en­vi­ron­ment

2 months ago
China
Pharma

Re­ci­pharm hits record rev­enue for 2024, eyes GLP-1 con­tracts for growth 

2 months ago
Pharma
First page Previous page 123456 Next page Last page
A service from the Financial Times